Greg Rhee Research – ER Visits for Suicide Attempts and Self-Harm

June 4, 2024

Greg Rhee

National Trends in Emergency Department Visits for Suicide Attempts and Intentional Self-Harm

Dr. Greg Rhee has gotten an important research article published in the Journal of Psychiatry. This study estimated national annual trends and characteristics of emergency department visits for suicide attempts and intentional self-harm in the United States from 2011 to 2020.

Article Excerpt:

Suicide continues to be a major public health problem in the United States, and suicide rates have risen by 35% since 2000 (1, 2). Suicide attempts are the single most important risk factor for suicide and the risk factor most likely to precipitate contact with the health care system (35). It is estimated that 1 in 25 individuals who present to the hospital for self-harm will die by suicide within 5 years (6). Since suicide prevention relies on identifying individuals at high risk for suicide, suicide attempts offer critical opportunities to intervene to prevent future suicide (79).

Since many patients are treated in emergency departments after a suicide attempt, emergency departments are an important setting for determining epidemiologic trends in suicidal behavior, especially because the United States does not have a national monitoring system for suicide attempts. Over the past three decades, several studies have raised concern about rising emergency department visits for suicide attempts (1013). A U.S. national study of emergency departments found that the average annual number of emergency department visits for suicide attempts and intentional self-harm more than doubled between 1993 and 2008 (11). A more recent study found that rates were stable between 2006 and 2013 (14).

Yet, there have been no nationally representative U.S. estimates of annual trends in emergency department visits for suicide attempts and intentional self-harm since 2013, including trends stratified by sociodemographic groups. Given the important role of emergency departments in suicide prevention, examining national trends in visits for suicide attempts provides an opportunity to identify population-wide unmet mental health needs and inform suicide prevention strategies.

Learn more here: https://ajp.psychiatryonline.org/doi/10.1176/appi.ajp.20230397

About Greg Rhee

Research Area(s) of Interest
Population-based clinical outcomes research and health care policy

Dr. Rhee is a psychiatric epidemiologist and mental health services researcher studying the access to care, quality of care, and clinical and patient-reported outcomes in patients with psychiatric or substance use disorders. My current research focuses on affective disorders (e.g., depression and bipolar disorder), suicidality, cannabis use disorder, and opioid use disorder among other conditions. My expertise is grounded in population-based observational studies using large databases to characterize unmet needs and national practice  patterns in the assessment and management of behavioral health conditions. I also investigate long-term comparative effectiveness and cost-effectiveness of pharmacological and non-pharmacological interventions for psychiatric and substance use disorders.

Dr. Rhee is an accredited professional statistician (PStat®) certified by the American Statistical Association with extensive experience with administrative claims data, national health and healthcare survey data, and other data sources including electronic health records, and mortality data. He has served as a senior statistician in 100+ peer-reviewed research articles and has successfully served as Principal Investigator or Co-Investigator on multiple research projects funded by major federal agencies, including Agency for Healthcare Research and Quality (AHRQ), Food and Drug Administration (FDA), and National Institutes of Health (NIH).

 

 

Dr. Rhee awarded $361,030 for NIH grant

Greg Rhee

Dr. Rhee was awarded $361,030 NIH grant for his nationwide project titled “Epidemiology and Clinical Outcomes of Electroconvulsive Therapy Use in Nursing Home Residents with Dementia.”

Electroconvulsive Therapy (ECT) can be an effective treatment modality for severe neuropsychiatric symptoms (NPS) (e.g., agitation and depression) in patients with Alzheimer’s disease and related dementias (ADRD). However, no nationwide epidemiologic study has previously conducted whether ECT is effective in reducing key clinical outcomes (e.g., hospitalizations and all-cause mortality rates) among older adults with ADRD in nursing home settings.

This study aims to examine the impact of ECT use on functional outcomes and mortality using nationally-representative data from Centers for Medicare and Medicaid Services (CMS) linked with other publicly available data sources. This two-year, NIH-funded study will be carried out in collaboration with the Department of Psychiatry at Harvard Medical School and McLean Hospital. Students interested in learning more about the study can reach out to Dr. Rhee for more information.

For more information, contact: Dr. Greg Rhee at rhee@uchc.edu

Maria (Mayte) Restrepo-Ruiz, PhD, is now an assistant professor

Having received her PhD in our department in 2021 for her study titled, “Armed Conflict, Intimate Partner Violence and Women’s Mental Health: An Explanatory Mixed-Methods Study.” She will continue her work with the Connecticut Office of Early Childhood as well as teach a course on Global Health in the Program in Applied Public Health Sciences.

Currently, Dr. Restrepo is working on building a surveillance system for Adverse and Positive Childhood Experiences in Connecticut using publicly available and administrative data sources. Data from this system will be used to  identify child populations at higher risk of adverse childhood experiences and gaps in the provision of prevention programs. She expects data from this system will be available to the public through a web portal in 2023. She is also collaborating with colleagues from Colombia and Puerto Rico on a project to understand better the role of potentially traumatic experiences in children’s mental health in socio-politically complex contexts.  Dr. Restrepo’s goal is to advance her research in preventing adverse experiences in childhood by focusing on factors that have been found to promote positive health outcomes despite adversity. 

Dr. Stacey Brown at The 100 Women of Color Gala & Awards

photo of stacey brown

Dr. Stacey Brown will be honored for her powerful impact on the community at The 100 Women of Color Gala & Awards. From the event coordinators:

From UConn Today: “On, Friday, June 24, 2022, June Archer & Eleven28 Entertainment will celebrate the power of family, friends and community, as we honor the past, the present and the future. The 100 Women of Color Gala & Awards will recognize the contributions that these women of color in business, education, entrepreneurship, entertainment, government, public service and the impact they have made on the lives of people throughout the State of Connecticut and Western Massachusetts communities.”

The event, organized by June Archer & Eleven28 Entertainment, will recognize the contributions of UConn’s honorees on the lives of people and other women in the State of Connecticut. Also, other women of color will be recognized from across the fields of business, education, entrepreneurship, entertainment, government, and public service.

The gala’s goal is to provide financial support for programs that support the advancement of young women of color. Event proceeds will support scholarships for young women who graduate from high school and plan on attending College, leadership and mentorship programs.

PHS Welcomes Dr. Youngji Jo

Youngji Jo

Youngji Jo, PhD, joins us as an assistant professor from the Boston University Clinical HIV/AIDS Research Training Program, Boston Medical Center. She has studied infectious diseases such as TB and HIV in the US and internationally, using statistical modeling to assess cost effectiveness of interventions and inform policy decisions.

Dr. Jo is an Assistant Professor/ Dr. Jo’s research approach 1) explores ways to construct health systems/cost-effectiveness models that account for epidemiologic factors as well as supply and demand-side constraints to improve efficiency, equity, and financial sustainability of the health system 2) elucidates the underlying processes and mechanisms that contribute to the outcome, beyond simple association and prediction, and 3) integrates new sources of data, methods, and practice, such as Digital Health, in expanding our  understanding of disease transmission pathways and improving current practice related to disease prevention and control. Her research has contributed to identifying the specific epidemic and health systems conditions and threshold points in which an intervention can achieve its optimal cost-effectiveness at scale or by targeting subpopulations. Dr. Jo’s current research interest includes developing a mathematical model to assess the clinical impact and cost-effectiveness for integrated and multi-month drug dispensing scenarios for people living with HIV and other chronic diseases to guide optimal drug dispensing strategy. Her long-term goals are to identify how dynamic trajectories of supply and demand-side factors might alter the existing understanding of causal relationships in the context of HIV/TB service delivery and develop a working model of health systems’ performance that can help design and implement HIV/TB prevention and treatment in resource-limited settings. 

PHS Welcomes Dr. Wenqi Gan

Wenqi Gan, MD, PhD, joins us as an associate professor in Epidemiology and Biostatistics. Dr. Gan received systematic training in clinical and preventive medicine, environmental and occupational health, especially methodological training in epidemiology and biostatistics. He has a medical degree in Preventive Medicine from Shanghai Medical University, and a PhD in Environmental Epidemiology from the University of British Columbia. Over the past 20 years, Dr. Gan has worked as an Epidemiologist and Biostatistician in the areas of cardiovascular diseases, chronic lung diseases, environmental and occupational health, and substance use disorders. He is interested and experienced in research methodology, including study designs, statistical methods, and data sciences. Dr. Gan actively pursues collaborative research and serves as a reliable resource for researchers who need assistance and support in research methodology at the School of Medicine.

 

PHS Welcomes Dr. Brian Reichow

Brian Reichow

Dr. Reichow’s current research interests include the translation of research to practice, the use of systematic review methods and meta-analytic methods to identify evidence-based practices, and applied research involving young children with or at risk of developing disabilities and their families. 

Dr. Brian Reichow is an Associate Professor of Public Health Sciences and Associate Director of the University of Connecticut Center for Excellence in Developmental Disabilities Education, Research, and Service. His current research interests include the translation of research to practice, the use of systematic review methods and meta-analytic methods to identify evidence-based practices, and applied research involving young children with or at risk of developing disabilities and their families. He has been a technical advisor for the World Health Organization for over a decade assisting WHO with the development of practice guidelines and training materials to increase the identification, management, and treatment of children with developmental disabilities in lower- and middle-income countries. This work recently led to the release of the World Health Organization Caregiver Skills Training for Families of Children with Developmental Delays or Disabilities (https://openwho.org/courses/caregiver-skills-training), an open-source program that is available freely through WHO. Dr. Reichow is currently Co-Editor in Chief of the Journal of Early Intervention, the leading journal in the field of early childhood special education and early intervention and is Co-Editor of the Disability Coordinating Group of the Campbell Collaboration and Campbell Systematic Reviews.